Savior Lifetec Corporation manufactures and supplies sterile pharmaceutical ingredients to the pharmaceutical community. The Company offers sterile API and finished dosage formulations including meropenem, imipenem and ertapenem.

Announcement That The Company Has Been Invited To
Participate In The Online Legal Person Briefing Held By
Horizon Securities.

To Clarify The Press Report

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Savior Lifetec (4167 TT)

Announcement That The Company Has Been Invited To Participate In The Online Legal Person Briefing Held By Horizon Securities.

To Clarify The Press Report

Acting On Behalf Of The Subsidiary Slc Biopharm Co., Ltd. To Announce The Handling Of Cash Capital Increase

Announcement Of The Scl Board Of Directors Approved The 2024 Third Quarter Consolidated Financial Statements

Announcement Of Important Resolutions Of The Board Of Directors Of The Company

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)